Figure 4
From: Stem cell factor SALL4, a potential prognostic marker for myelodysplastic syndromes
MDS patients with high SALL4 expression had worse survival rates. (A) Kaplan-Meier survival curves for MDS patients based on WHO subtypes. The RAEB-2 group with higher SALL4 and Bmi-1 expression levels showed a worse survival rate. (B) Kaplan-Meier survival curves for MDS patients based on IPSS risk groups. Int-2 and High risk groups had worse survival rates than Int-1 and Low risk groups. Correspondingly, SALL4 and Bmi-1 expression levels were also higher in Int-2 and High risk groups. (C) Kaplan-Meier survival curves for MDS patients based on Bmi-1 expression level. (D) Kaplan-Meier survival curves for MDS patients based on SALL4 expression level. * P-value<0.05 analyzed by log-rank test. The expression data on SALL4 and Bim-1 were presented as mean±SD.